Skip to main content
. 2014 Jun 20;64(4):636–645. doi: 10.1136/gutjnl-2013-306620

Figure 2.

Figure 2

Identification of somatic mutations by exome sequencing in 22 patients with CRC for genomic discovery. (A) Spectrum of nucleotide alterations was determined in each exome-sequenced patient with CRC. Nucleotide change was predominated by C/G>T/A transition. (B) The landscape of non-silent mutations at genome-wide scale was depicted with the height of each gene reflecting the mutation frequency among 22 patients with CRC. Three reported gene mountains (ie, APC, KRAS, TP53) were interspersed with many novel gene hills (eg, FAT4, NF1, DOCK2, HERC2) discovered in our CRC cohort.